SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014095
Filing Date
2023-08-09
Accepted
2023-08-09 08:05:57
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q omer-20230630x10q.htm   iXBRL 10-Q 1431966
2 EX-31.1 omer-20230630xex31d1.htm EX-31.1 11027
3 EX-31.2 omer-20230630xex31d2.htm EX-31.2 12230
4 EX-32.1 omer-20230630xex32d1.htm EX-32.1 8171
5 EX-32.2 omer-20230630xex32d2.htm EX-32.2 7722
  Complete submission text file 0001558370-23-014095.txt   7207048

Data Files

Seq Description Document Type Size
6 EX-101.SCH omer-20230630.xsd EX-101.SCH 57114
7 EX-101.CAL omer-20230630_cal.xml EX-101.CAL 71268
8 EX-101.DEF omer-20230630_def.xml EX-101.DEF 186145
9 EX-101.LAB omer-20230630_lab.xml EX-101.LAB 450221
10 EX-101.PRE omer-20230630_pre.xml EX-101.PRE 350547
67 EXTRACTED XBRL INSTANCE DOCUMENT omer-20230630x10q_htm.xml XML 1447125
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 231153443
SIC: 2834 Pharmaceutical Preparations